BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 26088864)

  • 1. Roxithromycin inhibits nuclear factor kappaB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates experimental colitis in mice.
    Choi Y; Koh SJ; Lee HS; Kim JW; Gwan Kim B; Lee KL; Kim JS
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1664-71. PubMed ID: 26088864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fexofenadine regulates nuclear factor-κB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates acute and chronic colitis in mice.
    Koh SJ; Kim JW; Kim BG; Lee KL; Chun J; Kim JS
    J Pharmacol Exp Ther; 2015 Mar; 352(3):455-61. PubMed ID: 25538104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril inhibits nuclear factor-κB signaling in intestinal epithelial cells and peritoneal macrophages and attenuates experimental colitis in mice.
    Lee C; Chun J; Hwang SW; Kang SJ; Im JP; Kim JS
    Life Sci; 2014 Jan; 95(1):29-39. PubMed ID: 24239644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ursolic acid inhibits nuclear factor-κB signaling in intestinal epithelial cells and macrophages, and attenuates experimental colitis in mice.
    Chun J; Lee C; Hwang SW; Im JP; Kim JS
    Life Sci; 2014 Aug; 110(1):23-34. PubMed ID: 24992474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant sterol guggulsterone inhibits nuclear factor-kappaB signaling in intestinal epithelial cells by blocking IkappaB kinase and ameliorates acute murine colitis.
    Cheon JH; Kim JS; Kim JM; Kim N; Jung HC; Song IS
    Inflamm Bowel Dis; 2006 Dec; 12(12):1152-61. PubMed ID: 17119390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory mechanism of metformin and its effects in intestinal inflammation and colitis-associated colon cancer.
    Koh SJ; Kim JM; Kim IK; Ko SH; Kim JS
    J Gastroenterol Hepatol; 2014 Mar; 29(3):502-10. PubMed ID: 24716225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifidobacterium lactis inhibits NF-kappaB in intestinal epithelial cells and prevents acute colitis and colitis-associated colon cancer in mice.
    Kim SW; Kim HM; Yang KM; Kim SA; Kim SK; An MJ; Park JJ; Lee SK; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2010 Sep; 16(9):1514-25. PubMed ID: 20310012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jianpi Qingchang decoction alleviates ulcerative colitis by inhibiting nuclear factor-κB activation.
    Zheng L; Zhang YL; Dai YC; Chen X; Chen DL; Dai YT; Tang ZP
    World J Gastroenterol; 2017 Feb; 23(7):1180-1188. PubMed ID: 28275298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lupeol inhibits LPS-induced NF-kappa B signaling in intestinal epithelial cells and macrophages, and attenuates acute and chronic murine colitis.
    Lee C; Lee JW; Seo JY; Hwang SW; Im JP; Kim JS
    Life Sci; 2016 Feb; 146():100-8. PubMed ID: 26767626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simvastatin inhibits NF-kappaB signaling in intestinal epithelial cells and ameliorates acute murine colitis.
    Lee JY; Kim JS; Kim JM; Kim N; Jung HC; Song IS
    Int Immunopharmacol; 2007 Feb; 7(2):241-8. PubMed ID: 17178392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice.
    Koh SJ; Kim JM; Kim IK; Kim N; Jung HC; Song IS; Kim JS
    Am J Physiol Gastrointest Liver Physiol; 2011 Jul; 301(1):G9-19. PubMed ID: 21436313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Histone Deacetylase 6 Inhibitor CKD-506 Inhibits NF-κB Signaling in Intestinal Epithelial Cells and Macrophages and Ameliorates Acute and Chronic Murine Colitis.
    Lee JW; Lee SM; Chun J; Im JP; Seo SK; Ha N; Il Choi Y; Kim JS
    Inflamm Bowel Dis; 2020 May; 26(6):852-862. PubMed ID: 31895948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Walnut phenolic extract inhibits nuclear factor kappaB signaling in intestinal epithelial cells, and ameliorates experimental colitis and colitis-associated colon cancer in mice.
    Koh SJ; Choi YI; Kim Y; Kim YS; Choi SW; Kim JW; Kim BG; Lee KL
    Eur J Nutr; 2019 Jun; 58(4):1603-1613. PubMed ID: 29744610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astragalin Inhibits Nuclear Factor-κB Signaling in Human Colonic Epithelial Cells and Attenuates Experimental Colitis in Mice.
    Han YM; Koh J; Kim JH; Lee J; Im JP; Kim JS
    Gut Liver; 2021 Jan; 15(1):100-108. PubMed ID: 32390406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel guggulsterone derivative GG-52 inhibits NF-kappaB signaling in intestinal epithelial cells and attenuates acute murine colitis.
    Kim JM; Kang HW; Cha MY; Yoo D; Kim N; Kim IK; Ku J; Kim S; Ma SH; Jung HC; Song IS; Kim JS
    Lab Invest; 2010 Jul; 90(7):1004-15. PubMed ID: 20195240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The guggulsterone derivative GG-52 inhibits NF-κB signaling in bone marrow-derived dendritic cells and attenuates colitis in IL-10 knockout mice.
    Kang SJ; Kim JM; Koh SJ; Kim SH; Im JP; Jung HC; Kim JS
    Life Sci; 2013 Jun; 92(22):1064-71. PubMed ID: 23603141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory effects of Brucea javanica oil emulsion by suppressing NF-κB activation on dextran sulfate sodium-induced ulcerative colitis in mice.
    Huang YF; Zhou JT; Qu C; Dou YX; Huang QH; Lin ZX; Xian YF; Xie JH; Xie YL; Lai XP; Su ZR
    J Ethnopharmacol; 2017 Feb; 198():389-398. PubMed ID: 28119098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Siglec-9 alleviates intestinal inflammation through inhibition of the NF-κB pathway.
    Kang EA; Soh H; Park S; Lee HJ; Im JP; Kim JS
    Int Immunopharmacol; 2020 Sep; 86():106695. PubMed ID: 32570035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limonin ameliorates dextran sulfate sodium-induced chronic colitis in mice by inhibiting PERK-ATF4-CHOP pathway of ER stress and NF-κB signaling.
    Song C; Chen J; Li X; Yang R; Cao X; Zhou L; Zhou Y; Ying H; Zhang Q; Sun Y
    Int Immunopharmacol; 2021 Jan; 90():107161. PubMed ID: 33168409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.